Cargando…

Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review

Various safe and effective COVID-19 vaccines utilizing different platforms (mRNA, adenovirus vector, inactivated virus-based) are available against SARS-CoV-2 infection. A prime-boost regimen (administration of two doses) is recommended to induce an adequate and sustained immune response. Most of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garg, Ishan, Sheikh, Abu Baker, Pal, Suman, Shekhar, Rahul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326526/ https://www.ncbi.nlm.nih.gov/pubmed/35893476 http://dx.doi.org/10.3390/idr14040057

Ejemplares similares

COVID-19 Vaccine Booster: To Boost or Not to Boost
por: Shekhar, Rahul, et al.
Publicado: (2021)

COVID-19 Vaccine in Pregnant and Lactating Women: A Review of Existing Evidence and Practice Guidelines
por: Garg, Ishan, et al.
Publicado: (2021)

Impact of COVID-19 on the Changing Patterns of Respiratory Syncytial Virus Infections
por: Garg, Ishan, et al.
Publicado: (2022)

COVID-19 Vaccine Hesitancy in the LGBTQ+ Population: A Systematic Review
por: Garg, Ishan, et al.
Publicado: (2021)

COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation
por: Sheikh, Abu Baker, et al.
Publicado: (2021)

COVID-19 and Influenza Coinfection Outcomes among Hospitalized Patients in the United States: A Propensity Matched Analysis of National Inpatient Sample
por: Garg, Ishan, et al.
Publicado: (2022)

Gender and Race-Based Health Disparities in COVID-19 Outcomes among Hospitalized Patients in the United States: A Retrospective Analysis of a National Sample
por: Pal, Suman, et al.
Publicado: (2022)

Heterologous prime boost COVID 19 vaccination
por: Launay, O., et al.
Publicado: (2022)

COVID-19 Vaccine Acceptance among Health Care Workers in the United States
por: Shekhar, Rahul, et al.
Publicado: (2021)

Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
por: Tan, C. Sabrina, et al.
Publicado: (2022)

COVID-19 and Pulmonary Embolism Outcomes among Hospitalized Patients in the United States: A Propensity-Matched Analysis of National Inpatient Sample
por: Nasrullah, Adeel, et al.
Publicado: (2022)

COVID-19 Vaccine Hesitancy and Attitude toward Booster Doses among US Healthcare Workers
por: Pal, Suman, et al.
Publicado: (2021)

COVID-19 and the Endocrine System: A Review of the Current Information and Misinformation
por: Mirza, Samir Ahmed, et al.
Publicado: (2022)

Trends in Hospitalization and Mortality for Influenza and Other Respiratory Viruses during the COVID-19 Pandemic in the United States
por: Nasrullah, Adeel, et al.
Publicado: (2023)

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
por: Nguyen, Thuy Trang, et al.
Publicado: (2022)

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
por: Shaw, Robert H, et al.
Publicado: (2021)

Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
por: Choudhary, Om Prakash, et al.
Publicado: (2021)

Acute exacerbation of psoriasis after COVID-19 Pfizer vaccination
por: Lopez, Erick Daniel, et al.
Publicado: (2021)

Antibody response induced by the boost overdose during COVID-19 heterologous prime-boost vaccination strategy
por: Raposo, Francisco, et al.
Publicado: (2021)

Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
por: Gelanew, Tesfaye, et al.
Publicado: (2023)

Emerging evidence on heterologous COVID-19 vaccine schedules—To mix or not to mix?
por: Parker, Edward P K, et al.
Publicado: (2022)

Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review
por: Sheikh, Abu Baker, et al.
Publicado: (2021)

Nationwide Analysis of the Clinical Outcomes of Patients Admitted With COVID-19 Infection With Myocarditis and Racial Disparities in Mortality
por: Cannon, Harmon R, et al.
Publicado: (2023)

Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
por: Cheng, Haoyue, et al.
Publicado: (2022)

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
por: He, Qian, et al.
Publicado: (2021)

Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Impact of COVID-19 on Patients Hospitalized with ST-Segment Elevation Myocardial Infarction in the United States during the Early Pandemic: An Analysis of Outcomes, Care Delivery, and Racial Disparities in Mortality
por: Majeed, Harris, et al.
Publicado: (2023)

Inferior Wall Myocardial Infarction in Severe COVID-19 Infection: A Case Report
por: Sheikh, Abu Baker, et al.
Publicado: (2020)

COVID-19 and NSTEMI Outcomes among Hospitalized Patients in the United States and Racial Disparities in Mortality: Insight from National Inpatient Sample Database
por: Majeed, Harris, et al.
Publicado: (2022)

Heterologous vaccine interventions: boosting immunity against future pandemics
por: Marín-Hernández, Daniela, et al.
Publicado: (2021)

The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

Adopting an heterologous prime-boost strategy in COVID-19 vaccination: the need for locally generated evidence in Africa
por: Oboh, Mary Aigbiremo, et al.
Publicado: (2022)

Correlation of adverse effects and antibody responses following homologous and heterologous COVID-19 prime-boost vaccinations
por: Cheng, Aristine, et al.
Publicado: (2023)

Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
por: Cheng, Aristine, et al.
Publicado: (2023)

Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
por: Banerjee, K, et al.
Publicado: (2012)

Diabetes Insipidus and Concomitant Myocarditis: A Late Sequelae of COVID-19 Infection
por: Sheikh, Abu Baker, et al.
Publicado: (2021)

Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report
por: Sheikh, Abu Baker, et al.
Publicado: (2021)

COVID-19 with non-obstructive coronary artery disease in a young adult
por: Sheikh, Abu Baker, et al.
Publicado: (2021)

Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months
por: Low, Ee Vien, et al.
Publicado: (2022)

COVID-19 Associated Myocarditis Clinical Outcomes among Hospitalized Patients in the United States: A Propensity Matched Analysis of National Inpatient Sample
por: Davis, Monique G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_90qg0nia732iu5hbsjhnpeqc9u